PharmacoEconomics & Outcomes News

, Volume 803, Issue 1, pp 20–20 | Cite as

PET/CT cost effective for selecting targeted treatment in breast cancer

Clinical study


  1. Koleva-Kolarova RG, et al. Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study. Oncotarget : 13 Apr 2018. Available from: URL:

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations